Dr. Ronald Charlton

Dr. Ronald Charlton is a distinguished physician and researcher specializing in transplantation medicine and immunogenetics. With a career spanning several decades, Dr. Charlton has made significant contributions to the understanding of various aspects of organ transplantation, genetic factors influencing immune responses, and immunological disorders.

Experience

Dr. Charlton's research interests have encompassed a wide range of topics, including the impact of ABO and HLA antibody sensitization on organ transplant outcomes, the development and evaluation of HLA typing products for laboratory use, and the outcomes of living kidney donation. His work has shed light on critical issues in transplantation medicine, such as donor-recipient matching, donor selection criteria, and post-transplant care.

Throughout his career, Dr. Charlton has been involved in numerous studies aimed at improving patient outcomes and advancing the field of transplantation. His research has contributed to the development of novel diagnostic and therapeutic approaches, as well as to our understanding of the complex interplay between genetic factors, immune function, and disease pathogenesis.

As a respected clinician-scientist, Dr. Charlton has authored and co-authored numerous articles in peer-reviewed journals, providing valuable insights into the molecular and cellular mechanisms underlying immune-mediated diseases and transplant rejection. His dedication to advancing medical knowledge and improving patient care has earned him recognition and respect within the medical community.

Publications

‍

• Wait time deconstructed; October 2015, Human Immunology 76:47, Jean Heneghan, Ronald K. Charlton; DOI:10.1016/j.humimm.2015.07.066
• 1018-LBP: Comparative study of biofortuna sspgo hla typing product (IUO/PEO); June 2014, Jean Heneghan, Kellie Jordan, Ronald K. Charlton; Human Immunology 75(6):488, DOI:10.1016/j.humimm.2014.01.030
• One hundred consecutive living kidney donors: Modern issues and outcomes; January 2003; Thomas G Peters, Suzanne M Repper, Mia Vincent, Colleen A Schonberg, Kenneth W Jones, Ivan Cruz, Ronald K. Charlton, Christopher s Mccullough, Richard D Hunter; Clinical Transplantation 16(s7):62 - 68; DOI:10.1034/j.1399-0012.16.s7.10.x
• Collecting serum samples for kidney patient testing: improving the return; Article Oct 2002; Terri D Permenter, Sheila K Conboy, Thomas G Peters, Ronald K. Charlton
• Living-unrelated kidney donation: A single-center experience; Article Mar 1999; Thomas G Peters, Kenneth W Jones, Ronald K. Charlton,George W Walker[...], R D Hunter
• SUCCESSFUL LIVING UNRELATED KIDNEY DONATION - TRANSPLANTATION: A FOUR YEAR EXPERIENCE; Article Oct 1998;  T G PETERS, K W JONES, Ronald K. Charlton[...], S M REPPER
• Molecular biology in transplantation medicine; Article Jan 1998; Ronald K. Charlton
• Current issues in living donor nephrectomy; Article Nov 1997; K W Jones, T G Peters, Ronald K. Charlton[...], E J Peters
• Altered Monocyte Calcium Dynamics in Sepsis; Article Jun 1997; Hyon Shin, Ronald K. Charlton, Daniel L. Mollitt
• Kidney transplantation in the older patient; Article Sep 1994; T G Peters, Ronald K. Charlton, K W Jones[...], T B King. 
• Psychological Modulation of the Delayed Type Hypersensitivity Skin Test; Article Feb 1992; G. Richard Smith, Carolyn Conger, Diane F. O’Rourke[...], Ronald K. Charlton, Susan S. Smith.
• T-lymphocyte subsets in nephrotic syndrome; Article Dec 1991; Richard T Fiser, Watson C Arnold, Ronald K. Charlton[...], Belinda L Shirkey. 
• Histocompatibility Determinants in Childhood Postinfectious Encephalomyelitis; Article Aug 1989;  Robert C. Woody, Russell W Steele, Ronald K. Charlton, Valaria Smith.
• Immune Function in Patients Treated With Phenytoin; Article Feb 1989; A. Wesley Burks, Ronald K. Charlton, Peggy Casey[...], Russell Steele.
• Effects of Ribavirin on Neutrophil Function; Article Jul 1988; Russell W Steele, DAVID L. CROSBY, NEYLON S. JR PILKINGTON, Ronald K. Charlton.
• Immune Modulators as Antiviral Agents; Article Jan 1988; Russell W Steele, Ronald K. Charlton.
• Functional capacity of marginated and bone marrow reserve granulocytes; Article Nov 1987; Russell W Steele, C R Steele, N S Pilkington, Ronald K. Charlton.
• Flow cytometric analysis of ploidy in the axolotl, Ambystoma mexicanum; Article Sep 1987; Patrick W. Tank, Ronald K. Charlton, E. Robert Burns
• Cryoprecipitate: a safe factor VIII replacement; Article Jun 1987; Morris Kletzel, Ronald K. Charlton, David Becton, D H Berry.
• A Comparison of Native and Modified Intravenous Immunoglobulin for the Management of Hypogammaglobulinemia; Article Feb 1987; Russell W Steele, R. ANN AUGUSTINE, ROBERT W. STEELE[...], Ronald K. Charlton.
• In Vitro Assay of Cytotoxicity with Cultured Liver: Accomplishments and Possibilities; Article Sep 1978; Joe Grisham, Ronald K. Charlton, David G. Kaufman.
• Increased sensitivity for detection of carcinogen-induced DNA repair with the chain terminator dideoxythymidine; Sep 1978; Gary J. Smith, Ronald K. Charlton, Joe Grisham, David G. Kaufman. 
• Ultrastructure of Cell Cultures on Polycarbonate Membranes; Jun 1977; Waykin Nopanitaya, Ronald K. Charlton, Robert L. Turchin, Joe Grisham. 
• Soluble HL-A7 Antigen: Localization in the beta-Lipoprotein Fraction of Human Serum; Dec 1970; Ronald K. Charlton, Chester M. Zmijewski

‍

‍